{"uri":"t-cell-activation-assay-hwhb7b6","version_id":"0","protocol_name":"T cell activation assay","protocol_name_html":"T cell activation assay","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"1","last_modified":"1522216802","type_id":"1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":"","public_fork_note":"","number_of_steps":"4","has_versions":"0","first_published_date":"1495050181","publish_date":"2017-05-17 19:43:01","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"<p>This protocol describes a method for detecting T cell activation in response to BiTE<strong>\u00ae<\/strong> treatment by flow cytometry .<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":"","has_guidelines":"0","materials":[],"warning":"","version_class":"5801","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1494375319","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.hwhb7b6","doi_status":"2","changed_fork_steps":null,"profile_url":"x2y284w2t2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/006.png","full_name":"Sandra Ross","created_by":"Sandra Ross","private_link":"0AC9AD15218859ACD643CAFF01F82E54","original_img":"1","username":"sandra-ross","is_retracted":"0","retraction_reason":null,"plos_id":"10.1371\/journal.pone.0183390","manuscript_citation":"Ross SL,  Sherman M,  McElroy PL,  Lofgren JA,  Moody G,  Baeuerle PA,  Coxon A,  Arvedson T, Bispecific T cell engager (BiTE) antibody constructs can mediate bystander tumor cell killing. PLoS ONE  12(8). doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0183390\">10.1371\/journal.pone.0183390<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":243357,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"1","collections":[{"protocol_name":"Collection of protocols accompanying \"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing\"","protocol_name_html":"Collection of protocols accompanying \"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing\"","uri":"collection-of-protocols-accompanying-bispecific-t-ib8carw","username":"sandra-ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","full_name":"Sandra Ross"}],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"4","badge_image":"\/img\/badges\/gold.svg","badge_description":"Gold power author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","authors_list":[{"name":"Sandra L. Ross","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Marika Sherman","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Patricia L. McElroy","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Julie A. Lofgren","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Gordon Moody","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Patrick A. Baeuerle","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Angela Coxon","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Tara Arvedson","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null}],"user":{"profile_image":"\/img\/avatars\/006.png","username":"sandra-ross","full_name":"Sandra Ross","created_by":"Sandra Ross"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":"","status_id":"1","is_research":"1","status_info":null,"steps":[{"id":"493567","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"A79119FE95D34BD3A4E0538F41DD09AF","previous_guid":null,"previous_id":"0","last_modified":"1494375438","components":[{"component_id":"797355","previous_id":0,"original_id":"0","guid":"7416A328CF6A4DB5B80132F7CB257FCA","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>Supernatants (containing T cells) are removed from TDCC assays (please refer to TDCC protocol). In a multiplexed flow cytometry assay, cells are stained with anti-CD45 (lymphocyte common antigen) and antibodies to the T cell activation markers CD25 and CD69. CD45 positivity distinguishes T cells from cell debris. Analysis identifies the populations that are CD45<sup>+<\/sup> and CD69<sup>+<\/sup> and\/or CD25<sup>+<\/sup>.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Supernatants (containing T cells) are removed from TDCC assays (please refer to TDCC protocol). In a multiplexed flow cytometry assay, cells are stained with anti-CD45 (lymphocyte common antigen) and antibodies to the T cell activation markers CD25 and CD69. CD45 positivity distinguishes T cells from cell debris. Analysis identifies the populations that are CD45<sup>+<\/sup> and CD69<sup>+<\/sup> and\/or CD25<sup>+<\/sup>.<\/p>"},"is_project":0},{"component_id":"797353","previous_id":"797355","original_id":"0","guid":"D042DE98FC2F4D19AEE2965AF7E2E4B4","previous_guid":"7416A328CF6A4DB5B80132F7CB257FCA","component_type_id":"6","data_id":"0","data":"Overview","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Overview"},"is_project":0}]},{"id":"493571","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"3CF91D89EDF04866A6997E687FA3D2CE","previous_guid":"A79119FE95D34BD3A4E0538F41DD09AF","previous_id":"493567","last_modified":"1494375502","components":[{"component_id":"797365","previous_id":0,"original_id":"0","guid":"76E24305A5FA4A60AC6FED67F7F3FDB9","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<table width=\"827\">\n<tbody>\n<tr>\n<td width=\"420\">\n<p><strong>Materials<\/strong><\/p>\n<\/td>\n<td width=\"251\">\n<p><strong>Company<\/strong><\/p>\n<\/td>\n<td width=\"156\">\n<p><strong>Cat.no.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Sterile 96-well clear V-bottom polypropylene plates<\/p>\n<\/td>\n<td width=\"251\">\n<p>Greiner<\/p>\n<\/td>\n<td width=\"156\">\n<p>651201<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>1x PBS<\/p>\n<\/td>\n<td width=\"251\">\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>14190<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Mouse anti-human CD45-APC<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD Biosciences<\/p>\n<\/td>\n<td width=\"156\">\n<p>555485<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Mouse anti-human CD69-FITC<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD Biosciences<\/p>\n<\/td>\n<td width=\"156\">\n<p>555530<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Mouse anti-human CD25-PE<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD Biosciences<\/p>\n<\/td>\n<td width=\"156\">\n<p>341009<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<table width=\"827\">\n<tbody>\n<tr>\n<td width=\"420\">\n<p><strong>Materials<\/strong><\/p>\n<\/td>\n<td width=\"251\">\n<p><strong>Company<\/strong><\/p>\n<\/td>\n<td width=\"156\">\n<p><strong>Cat.no.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Sterile 96-well clear V-bottom polypropylene plates<\/p>\n<\/td>\n<td width=\"251\">\n<p>Greiner<\/p>\n<\/td>\n<td width=\"156\">\n<p>651201<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>1x PBS<\/p>\n<\/td>\n<td width=\"251\">\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>14190<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Mouse anti-human CD45-APC<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD Biosciences<\/p>\n<\/td>\n<td width=\"156\">\n<p>555485<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Mouse anti-human CD69-FITC<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD Biosciences<\/p>\n<\/td>\n<td width=\"156\">\n<p>555530<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Mouse anti-human CD25-PE<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD Biosciences<\/p>\n<\/td>\n<td width=\"156\">\n<p>341009<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>"},"is_project":0},{"component_id":"797357","previous_id":"797365","original_id":"0","guid":"C07297F9C3C54BF9BF0F3D9BD9D4924E","previous_guid":"76E24305A5FA4A60AC6FED67F7F3FDB9","component_type_id":"6","data_id":"0","data":"Assemble materials","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Assemble materials"},"is_project":0}]},{"id":"493581","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"297B8DF9196648FA89BBB8CB98CAB4CA","previous_guid":"3CF91D89EDF04866A6997E687FA3D2CE","previous_id":"493571","last_modified":"1494375528","components":[{"component_id":"797372","previous_id":0,"original_id":"0","guid":"3D8C260E3EDD46C9A57F431CCB7E40BE","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<ul>\n<li>FACS buffer (cold PBS + 2% FBS)<\/li>\n<li>Prepare master mix: 25 \u00b5l PBS + 250 \u00b5l each mouse anti-human CD45-APC, CD69-FITC and CD25-PE<\/li>\n<\/ul>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ul>\n<li>FACS buffer (cold PBS + 2% FBS)<\/li>\n<li>Prepare master mix: 25 \u00b5l PBS + 250 \u00b5l each mouse anti-human CD45-APC, CD69-FITC and CD25-PE<\/li>\n<\/ul>"},"is_project":0},{"component_id":"797367","previous_id":"797372","original_id":"0","guid":"8473E5DD7B04447793E364EB2F0181F7","previous_guid":"3D8C260E3EDD46C9A57F431CCB7E40BE","component_type_id":"6","data_id":"0","data":"Prepare reagents","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Prepare reagents"},"is_project":0}]},{"id":"493587","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"298F0A237A384EE6B765BBAD7DDD9F13","previous_guid":"297B8DF9196648FA89BBB8CB98CAB4CA","previous_id":"493581","last_modified":"1494375594","components":[{"component_id":"797383","previous_id":0,"original_id":"0","guid":"E66921AE48084BD0A1ED6DB481985860","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<ul>\n<li>Resuspend pelleted T cells in 100 \u00b5l cold FACS buffer (PBS + 2% FBS)<\/li>\n<li>Centrifuge at 300 x g for 10 min at 4\u00b0C<\/li>\n<li>Remove supernatants with vacuum manifold or pipet<\/li>\n<li>Add 100 \u00b5l cold FACS buffer\/well<\/li>\n<li>Centrifuge at 300 x g for 10 min at 4\u00b0C<\/li>\n<li>Remove supernatant with a vacuum manifold or a pipet and resuspend cells in 60 \u00b5l cold FACS buffer.<\/li>\n<li>Add 30 \u00b5l cold master mix to each well<\/li>\n<li>Mix and incubate for 30 min at 4\u00b0C<\/li>\n<li>Wash 2 times with 100 \u00b5l cold FACS buffer, as above<\/li>\n<li>Resuspend cells in 100 \u00b5l cold FACS buffer<\/li>\n<li>Acquire data on FACS CANTO<\/li>\n<\/ul>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ul>\n<li>Resuspend pelleted T cells in 100 \u00b5l cold FACS buffer (PBS + 2% FBS)<\/li>\n<li>Centrifuge at 300 x g for 10 min at 4\u00b0C<\/li>\n<li>Remove supernatants with vacuum manifold or pipet<\/li>\n<li>Add 100 \u00b5l cold FACS buffer\/well<\/li>\n<li>Centrifuge at 300 x g for 10 min at 4\u00b0C<\/li>\n<li>Remove supernatant with a vacuum manifold or a pipet and resuspend cells in 60 \u00b5l cold FACS buffer.<\/li>\n<li>Add 30 \u00b5l cold master mix to each well<\/li>\n<li>Mix and incubate for 30 min at 4\u00b0C<\/li>\n<li>Wash 2 times with 100 \u00b5l cold FACS buffer, as above<\/li>\n<li>Resuspend cells in 100 \u00b5l cold FACS buffer<\/li>\n<li>Acquire data on FACS CANTO<\/li>\n<\/ul>"},"is_project":0},{"component_id":"797374","previous_id":"797383","original_id":"0","guid":"9EC0D811BC0244619A1B9ED75915CAD8","previous_guid":"E66921AE48084BD0A1ED6DB481985860","component_type_id":"6","data_id":"0","data":"Prepare T cells for flow cytometry","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Prepare T cells for flow cytometry"},"is_project":0}]}]}